Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 12—December 2014

Francisella tularensis Bacteria Associated with Feline Tularemia in the United States

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Marilynn A. LarsonComments to Author , Paul D. Fey, Steven H. Hinrichs, and Peter C. Iwen
Author affiliations: University of Nebraska Medical Center, Omaha, Nebraska, USA

Cite This Article


Tularemia in the United States was examined by reviewing 106 Francisella tularensis isolates, mostly from Nebraska, collected during 1998–2012: 48% of Nebraska cases were cat-associated; 7/8 human cases were caused by subtype A.I. A vaccine is needed to reduce feline-associated tularemia, and cat owners should protect against bites/scratches and limit their pet’s outdoor access.

Francisella tularensis, a Tier 1 select agent, is one of the most pathogenic bacteria known and the etiologic agent of the zoonotic disease tularemia (1,2). Although the various subspecies of F. tularensis share considerable genomic content (>97% nt identity), they exhibit different degrees of virulence (3). F. tularensis subspecies tularensis (also known as type A) and subspecies holarctica (also known as type B) infections can be life-threatening if untreated (1). Type A is further subdivided into subtypes A.I and A.II; clade A.I contains strains that are associated with considerably higher death rates among humans than are the other members of this pathogenic species (4). Type B infections occur throughout the Northern Hemisphere, whereas type A infections occur primarily in North America (3).

Fatal and nonfatal cases of tularemia in domestic cats (Felis catus) have been reported, as has the transmission of this disease from cats to humans (57). Previous serologic surveys from several geographic regions determined that 12% of the domestic cats examined had antibodies to F. tularensis (8). Cases of feline-associated tularemia in humans continue to appear in the literature. However, the relative contribution of this source of F. tularensis transmission to humans is unknown and may be underrecognized. This study was conducted to examine the relative proportion and characteristics of feline-associated F. tularensis isolates within the repository at the University of Nebraska Medical Center (UNMC).

The Study

A review was conducted of the 106 wild-type F. tularensis isolates voluntarily deposited in the UNMC collection during 1998–2012. These isolates were obtained from infected humans, animals, or ticks predominantly residing in Nebraska; however, isolates from several other regions were also included. Wild-type F. tularensis isolates had been transferred to UNMC from other locations, according to requirements of the national Select Agent Program (2). None of these isolates had been solicited from veterinary or environmental reference laboratories. Species identity for locally detected wild-type F. tularensis isolates to which humans had been exposed was confirmed by the Nebraska Public Health Laboratory in Omaha. Viable culture material was manipulated by authorized persons following select agent–approved Biosafety Level 3 criteria. For genotyping, we used the PCR-based differential insertion sequence amplification (DISA) method with the CR10 C+L+S primer set and pulsed-field gel electrophoresis (PFGE) of PmeI-digested Francisella spp. DNA, as previously described (9).


Thumbnail of Molecular genotyping of Francisella tularensis isolates obtained from infected cats or humans bitten by an infected cat, United States, 1998–2012, Genotyping was performed by using pulsed-field gel electrophoresis (PFGE) and the PCR-based differential insertion sequence amplification (DISA) assay. A dendrogram of PFGE patterns obtained with PmeI-digested F. tularensis isolates is shown on the left; the scale bar at the top indicates distance in relative units. The genotype-specific

Figure. Molecular genotyping of Francisella tularensis isolates obtained from infected cats or humans bitten by an infected cat, United States, 1998–2012. Genotyping was performed by using pulsed-field gel electrophoresis (PFGE) and the...

Of the 106 wild-type F. tularensis isolates in the repository, 54 (51%) were from humans for whom the source of exposure was unknown or undocumented, 29 (27%) were from cats (21) or from humans (8) with tularemia linked to infected cats, 5 (5%) were from humans with tularemia linked to infected ticks, 1 (1%) was from a human with tularemia linked to an infected rabbit, 16 (15%) were from animals with tularemia, and 1 (1%) was from an unknown host. Of the 29 isolates derived from feline-associated cases, 28 were associated with domestic cats and 1 involved a feral cat (Figure). Eight cases of human tularemia occurred through a cat bite: 7 of these cases involved adults and 1 involved a 6-year-old child. In 2 cases, the person was bitten while taking a rabbit from a cat. None of the 8 humans died.

We also analyzed a subset of the 29 F. tularensis isolates obtained from cats or humans bitten by cats. All but 2 of the 29 isolates were available for genotyping. DISA and PFGE results showed that 1 type B and 26 subtype A.I strains were responsible for the 27 cases of tularemia (Figure). Of the 8 cat bite–associated human tularemia cases, 1 was caused by a type B and 7 by subtype A.I strains. None of the feline-associated tularemia cases were caused by a subtype A.II strain.

PFGE demonstrated that the feline-derived F. tularensis A.I strains could be further divided into 4 subpopulations. For strains in 1 of these subpopulations, DISA results showed chromosomal polymorphisms in which a 1.2-kbp or a 1.5-kbp amplicon was produced. This finding is consistent with 2 unique origins for the strains, even though they were obtained from the same geographic area.

Subset analysis of Nebraska cases showed that 48% (24/50) of the wild-type F. tularensis isolates were feline-associated, and most of those 24 isolates (71%, 17/24) were associated with tularemia cases that occurred in 1 city in eastern Nebraska. The highest number of tularemia cases in Nebraska was reported in 2012, a year noted for extreme heat and drought conditions with warm weather beginning in early January and lasting through December. No feline-associated tularemia cases in Nebraska were reported during 1998–2004; however, 18 were reported during 2005–2011.


Two different molecular methods demonstrated that F. tularensis subtype A.I was responsible for most of the tularemia cases in cats (96%, 26/27); 1 of the 27 cases was caused by a type B strain. This finding is consistent with subtype A.I strains being found predominantly east of the 100th meridian in the United States, whereas A.II strains appear to be restricted to the west of this meridian (4). More importantly, this study confirms that the highly virulent A.I strains are frequent causes of tularemia in cats and humans, a finding that is in agreement with those in a previous report (4), and that the type B clade can cause disease in these hosts.

Although cats are a well-known vector of F. tularensis, the strikingly high percentage of disease associated with cats in Nebraska was unexpected (48% in Nebraska vs. 27% in the UNMC repository). Of note, the highest number of feline-derived tularemia cases occurred in a city known to have multiple feral cat colonies and during a year with extended warm weather and extreme drought conditions. Warmer temperatures can accelerate the tick life cycle, augmenting the potential for transmission of vector-borne diseases (10,11), and droughts can contribute to impaired host immunity, thereby increasing the likelihood for the transmission of zoonotic pathogens at the limited sources of water (12). Therefore, although the natural reservoir of F. tularensis is unknown, we speculate that these environmental conditions exacerbated the spread of tularemia by increasing the abundance of ticks harboring and transmitting F. tularensis to outdoor animals. Nevertheless, the high relative contribution of cats to disease may be due to underrecognition of an existing problem, a new emerging threat caused by environmental factors, and/or reporting or other biases.

A 2012 systematic review reported that free-ranging domestic cats are probably responsible for the greatest percentage of bird and mammal deaths (13). This information and the findings from the current study support the supposition that although cats are considered incidental hosts for F. tularensis, their inherent predatory behavior increases the likelihood that they will acquire tularemia through the consumption of infected animals and exposure to contaminated ticks, animals, or water harboring this pathogen. A vaccine for tularemia is not available in the United States, and the overall prognosis for infected persons is poor if antibiotic drug treatment is not administered early in the infection process. Therefore, cat owners should protect themselves against potential bites and/or scratches and consider limiting outdoor access for domestic cats. In addition, because tularemia is often initially misdiagnosed (14), confirmatory testing by public health laboratories is important and will provide critical surveillance information regarding F. tularensis in the environment.

The high percentage of feline-associated tularemia cases reported in this study demonstrates that outdoor domestic cats are frequent vectors of F. tularensis, particularly in areas where the bacterium is endemic. The cases reported in this study were primarily from urban areas with nearby access to veterinarians and with cat owners/caretakers motivated to treat infected animals; therefore, our findings may not accurately estimate the prevalence of this pathogen within the feral and rural domestic cat populations. These findings do emphasize the importance of taking appropriate measures to reduce the transmission of feline-associated tularemia to humans and the need for a vaccine that protects against the highly virulent pathogen F. tularensis.

Dr Larson is an assistant professor in the Pathology and Microbiology Department at the University of Nebraska Medical Center in Omaha. Her research interests include the development of diagnostics and therapeutics for pathogen identification and treatment, respectively, as well as determining the molecular mechanisms that allow pathogens to replicate and persist.



We thank the Nebraska Public Health Laboratory for providing the bacterial isolates.

This study was funded in part by the Department of Pathology and Microbiology at the University of Nebraska Medical Center.



  1. Sjöstedt  A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann N Y Acad Sci. 2007;1105:129 and. DOIPubMedGoogle Scholar
  2. Centers for Disease Control and Prevention, Department of Health and Human Services (HHS). Possession, use, and transfer of select agents and toxins; final rule. Fed Regist. 2012;77:61083115 .PubMedGoogle Scholar
  3. Pechous  RD, McCarthy  TR, Zahrt  TC. Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev. 2009;73:684711 and. DOIPubMedGoogle Scholar
  4. Kugeler  KJ, Mead  PS, Janusz  AM, Staples  JE, Kubota  KA, Chalcraft  LG, Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis. 2009;48:86370 and. DOIPubMedGoogle Scholar
  5. Arav-Boger  R. Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin. Pediatr Infect Dis J. 2000;19:5834 and. DOIPubMedGoogle Scholar
  6. Capellan  J, Fong  IW. Tularemia from a cat bite: case report and review of feline-associated tularemia. Clin Infect Dis. 1993;16:4725 and. DOIPubMedGoogle Scholar
  7. Liles  WC, Burger  RJ. Tularemia from domestic cats. West J Med. 1993;158:61922 .PubMedGoogle Scholar
  8. Magnarelli  L, Levy  S, Koski  R. Detection of antibodies to Francisella tularensis in cats. Res Vet Sci. 2007;82:226 and. DOIPubMedGoogle Scholar
  9. Larson  MA, Fey  PD, Bartling  AM, Iwen  PC, Dempsey  MP, Francesconi  SC, Francisella tularensis molecular typing using differential insertion sequence amplification. J Clin Microbiol. 2011;49:278697 and. DOIPubMedGoogle Scholar
  10. Tabachnick  WJ. Challenges in predicting climate and environmental effects on vector-borne disease episystems in a changing world. J Exp Biol. 2010;213:94654 and. DOIPubMedGoogle Scholar
  11. Estrada-Peña  A, Gray  JS, Kahl  O, Lane  RS, Nijhof  AM. Research on the ecology of ticks and tick-borne pathogens—methodological principles and caveats. Front Cell Infect Microbiol. 2013;3:29.
  12. Altizer  S, Dobson  A, Hosseini  P, Hudson  P, Pascual  M, Rohani  P. Seasonality and the dynamics of infectious diseases. Ecol Lett. 2006;9:46784 and. DOIPubMedGoogle Scholar
  13. Loss  SR, Will  T, Marra  PP. The impact of free-ranging domestic cats on wildlife of the United States. Nat Commun. 2013;4:1396.
  14. Weber  IB, Turabelidze  G, Patrick  S, Griffith  KS, Kugeler  KJ, Mead  PS. Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. Clin Infect Dis. 2012;55:128390 and. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2012.131101

Table of Contents – Volume 20, Number 12—December 2014

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Marilynn A. Larson, Department of Pathology and Microbiology, University of Nebraska Medical Center, 985900 Nebraska Medical Center, Omaha, NE 68198-5900, USA

Send To

10000 character(s) remaining.


Page created: November 19, 2014
Page updated: November 19, 2014
Page reviewed: November 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.